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CC BY-NC-ND license (http://creativeAbstract Objective: To establish a collagen type II-induced rat model of rheumatoid arthritis
(RA) presenting characteristics of the human form of the traditional Chinese syndrome pattern
of toxic heat-stasis painful obstruction (bi zheng; arthromyodynia) as well as pathologic fea-
tures of active RA. The Chinese herbal medicine Tengmei decoction was used to validate
the animal model.
Methods: Ninety specific pathogen free Sprague-Dawley rats were randomly divided into a
normal group of 6 rats and a model group of 84 rats. To establish the rat model of collagen-
induced arthritis (CIA), bovine type II collagen in complete Freund’s adjuvant was injected into
the model group rats as a priming dose (Day 0) and boosting dose (Day 9). Changes in arthritic
index (AI) scores, including limb swelling, were monitored. Thereafter, 24 successfully-
established CIA rats were randomly assigned to 4 groups with 6 animals each: model, positive
control drug, high-dose traditional Chinese herbal medicine, and traditional Chinese herbal
medicine. A blank control group of 6 rats was included. After 12 weeks of intervention with
Tengmei decoction, articular synovial tissue and serum specimens were collected to detect
interleukin-2 (IL-2) and IL-17 transcription and protein expression levels.520056890
(F. Meng).
f Beijing University of Chinese Medicine.
16.01.002
f Chinese Medicine. Production and hosting by Elsevier B.V. This is an open access article under the
commons.org/licenses/by-nc-nd/4.0/).
Preparation and analysis of active rat model of rheumatoid arthritis 167Results: Days 0 through 9, the anterioreposterior and lateral diameters of the limbs in model
group rats did not differ significantly when compared to the normal control group (P > .05).
On day 16, anterioreposterior, lateral diameters, and footpad thicknesses of both hind limbs
in the model group were higher than those of the normal control group (P < .01, P < .05). Total
AI, AI of both hind limbs between Days 11 and 16 were significantly higher than those of the
normal control group (P < .01). Real-time reverse transcription polymerase chain reaction
analyses of rat joint tissues indicated that compared to the normal control group, levels of mRNA
transcription of IL-2 and IL-17 were significantly upregulated (P < .01) in the model group.
Compared with the model group, levels of mRNA transcription of the aforementioned inflamma-
tory cytokines were significantly downregulated in the positive control drug and traditional
Chinese medicine treatment groups (P< .01). Results of ELISA analyses indicated that compared
with the normal control group, levels of protein expression of cytokines IL-2, IL-17 were signi-
ficantly upregulated (P < .01) in the model group. Compared with the model group, levels of
protein expression of the aforementioned inflammatory cytokines were significantly downregu-
lated in the positive control drug and traditional Chinese medicine treatment groups (P < .01).
Conclusion: The CIA model established in this study presents both active RA pathologic features
and characteristics of the symptoms of toxic heat-stasis painful obstruction 12 weeks after
successful establishment of an animal model. In addition, this studymay be a valuable reference
for development of animal studies with combined Eastern and Western medicines in dialectics
and identification of diseases.
ª 2015 Beijing University of Chinese Medicine. Production and hosting by Elsevier B.V. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).Introduction
Rheumatoid arthritis (RA) is a common immune-mediated
inflammatory disease (IMID) that mainly affects joints and
often leads todisability. Basic pathologic changesare chronic
synovial inflammation manifesting as symmetric and erosive
arthritis of peripheral joints, pannus formation, and carti-
lagedestruction. In traditional Chinesemedicine (TCM), RA is
classified under the broad category of painful obstruction (bi
zheng; arthromyodynia). However, each disease stage has
different symptoms. For this reason, experimental models
approximating specific pathologic stages of human RA are
important for understanding the mechanism of RA and the
mechanism of medications used to treat RA.
There are currently two main types of RA animal models:
adjuvant-induced arthritis (AIA) and collagen-induced
arthritis (CIA).1 The AIA model is quite different from
human RA, with lesions being self-limited in rats. In the rat
CIA model, occurrence of a large number of lymphocytes
infiltrating the synovium, and development of synovial hy-
perplasia, synovial cell swelling, and new vascular networks
basically resemble the pathogenesis of human RA.2e4
Therefore, the CIA rat model is widely used in experi-
mental studies on RA.
In this study, we used the CIA modeling approach to
establish a rat model mimicking the characteristic symp-
toms of toxic heat-stasis type of painful obstruction with
pathologic features of active RA.4
To validate the animal model, the TCM herbal formula
Tengmei decoction was administered to rats. Tengmei
decoction is commonly prescribed in China to treat RA. Its
TCM functions are to clear heat, resolve toxin, transform
stasis, and remove turbidity with the treatment goal of
alleviating systemic and local symptoms and improving
abnormal serum indices of active RA. In this study, Tengmeidecoction was used as the intervention control drug to test
our hypothesis that the rat model of CIA mimics the TCM
pattern of painful blockage. The effects of the formula
were assessed by detecting its inhibition on immune and
inflammatory markers in the joint synovium of rats.
Materials and methods
Experimental animals
A total of 90 specific pathogen free (SPF) Sprague-Dawley
(SD) rats weighing 200e220 g were purchased from Vital
River Laboratories (Beijing, China). All rats were housed in
the barrier facility of the Institute of Chinese Materia
Medica of the China Academy of Traditional Chinese Medi-
cal Sciences, Beijing. Conditions of the facility were
18e24C and a relative humidity of 40e70%. Animals had
free access to standard chow and tap water.
Reagents and instruments
Reagents: Bovine type II collagen (bovine CII) was pur-
chased from Chondrex (Redmond, WA, USA); complete
Freund’s adjuvant (CFA) was purchased from SigmaeAldrich
(St. Louis, MO, USA); TRIzol reagent for extracting total RNA
(Invitrogen, Carlsbad, CA, USA); One Step SYBR RT-PCR Kit
(quantitative real-time PCR kit designed for SYBR Green I-
enabled product detection; Takara Bio, Kyoto, Japan);
GAPDH, target gene upstream and downstream primers
(Invitrogen); Rat IL-17 ELISA kit (eBioscience, San Diego,
CA, USA); Anti-NF-kB P65 antibody (ab131485; Abcam,
Bristol, UK). Instruments: Applied Biosystems 7500 quanti-
tative PCR system (ThermoFisher Scientific, Waltham, MA,
USA); TC-96-G/H (b)gradient PCR system (Bioer Technology,
168 Y. Wang et al.Hangzhou, China); ultraviolet spectrophotometer UV-2000
(Unico Instrument Shanghai, China); RT-6000 microplate
reader (Rayto, Shenzhen, China); DYY-10 electrophoresis
apparatus (Beijing Liuyi Instrument Factory, Beijing,
China). Tengmei decoction was prepared with the following
substances: 30 g honeysuckle vine (Lonicera japonica
Thunb.), 15 g mock strawberry [Duchesnea indica (Jacks.)
Focke]; 10 g Cantor’s rat snake (Zaocys dhumnades
(Cantor)); 30 g mulberry twig (Morus alba L.); 10 g white
mustard seed (Sinapis alba L.); and 10 g myrrh (Commi-
phora myrrha). The Department of Pharmacy, Dongfang
Hospital, prepared the decoction.Grouping and model construction
Grouping
Using a random number table, the 90 rats were divided into
a normal group of 6 rats and a model group of 84 rats. All
animals were fed adaptively for 1 week before model
construction.
Solution preparation
0.1 M acetic acid: Under sterile conditions, 114 mL of glacial
acetic acid was pipetted into a 50 mL centrifuge tube, into
which 20 mL of sterile water for injection was added. The
solution was gently mixed by vibrating. The resultant 0.1 M
acetic acid solution was refrigerated at 4C for later use.
Bovine CII acetic acid solution: 15 mL of prepared 0.1 M
acetic acid was added to 30 mg of frozen bovine CII powder.
The solution was gently stirred in an ice bath until the
collagen was completely dissolved, and the solution turned
colorless and transparent. The resultant concentration was
2 mg/mL. The collagen solution was stored at 4C away from
light for later use. Bovine CII and CFA emulsion: Two 50 mL-
syringes were used, one to draw 15 mL of prepared CII acetic
acid solution and the other to draw 15mL of CFA. The syringe
needles were removed and the air in the syringes was
expelledasmuchaspossible. Tubing (approximately 4e5 cm)
from an infusion set was used to connect the 2 syringes,
resulting in a self-made emulsifier. In an ice bath, the CII
acetic acid solutionwas first quickly emptied into the syringe
containing CFA, and themixed solutionwas then pushedback
into the other syringe. This entire process was performed in
an ice bath and was repeated. The tight connection between
the tubing and syringes was monitored for leakage. When
resistance of the syringes was significantly reduced upon
pushing and the solution in the syringes becamemilky, a drop
of the emulsified solution was removed and placed in clear
water. Emulsification was considered complete when the
emulsion drop floated on water without diffusing. The final
concentration was 1 mg/mL. The emulsion was stored at 4C
away from light for later use.
Establishing CIA model of rheumatoid arthritis
Model group rats were immunized with 200 mL of bovine CII-
CFA emulsion (containing 200 mg of CII) by injection at the
base of the tail. Booster immunization was performed 9
days later by injecting 100 mL of bovine II-CFA emulsion
(containing 100 mg of CII). Rats in the normal control group
were injected with an equal volume of saline.Evaluating rheumatoid arthritis in rats
On Day 0 and starting 1 week after the booster dose was
administered (16 days after immunization), CIA model rats
were evaluated, including general appearance, body
weight, and changes in the swelling of limbs. To measure
limb swelling, a vernier caliper was used. Sites that were
measured included thicknesses of the palm pads of both
forelimbs, the wrist strip perpendicular to the palm
(anterioreposterior diameter), the wrist strip between
lateral points of the radius and ulna (lefteright diameter),
footpads of both hindlimbs, between the posterior strip of
the ankle and heel (anterioreposterior diameter), and be-
tween the high points of the medial and lateral aspects of
the ankle (lefteright diameter).
Arthritis index (AI) was determined by the method per
Chondrex5: 0 point, normal; 1 point, mild swelling of wrist/
ankle, swelling limited to a single joint, or a few joints; 2
points, moderate wrist/ankle swelling confined to a single
wrist/ankle and not involving other interphalangeal joints;
3 points, severe wrist/ankle swelling affecting the paws
(dorsum of the foot and metacarpophalangeal/meta-
tarsophalangeal joints); 4 points, swelling of the entire limb
affecting multiple joints. Rats with AI  4 were considered
successful models.Study on the mechanism of Tengmei Decoction in
CIA model rats
Grouping and intervention methods
Twenty-four successfully-established CIA rats were
randomly assigned to 4 groups with 6 animals in each:
model, positive control drug, high-dose traditional Chinese
medicine (TCM), and traditional Chinese medicine (TCM)
groups. A normal control group of 6 rats was also included.
The model and normal control groups were given distilled
water (10 mL/kg per day). The positive control drug group
was given leflunomide (LEF), an immunosuppressive
disease-modifying anti-rheumatic drug (1.87 g/kg per day).
The traditional Chinese medicine group was administered
crude medicine (15.9 g/kg per day). The high-dose tradi-
tional Chinese medicine group received a dosage twice
higher than that of the traditional Chinese medicine group.
Animals in all groups were administered their respective
substances by gavage. Dosages used in the positive and
traditional Chinese medicine groups were equivalent to 5.6
times the human clinical dosages. Duration of the inter-
vention study was 12 weeks.
Effects of Tengmei Decoction on inflammatory factors in
CIA model rats
Real-time reverse transcription polymerase chain reaction
(RT-PCR) detection of IL-2 and IL-17 mRNA transcription in
joint synovial tissue of CIA model rats: Design and synthesis
of the primer were first carried out. Upstream and down-
stream IL-2 gene sequence primers were, respectively 50-
TAACCTCAACTCCTGCC ACAA TGTACA-30 and 50-
ATGTTGTTTCAGATCCCTTTAGTTCCAGA-30. For the up-
stream and downstream IL-17 gene sequences of primers
were, respectively, 50-TACAACCTCCTTGCAGCTCC-30 and 50-
GGATCTTCATGAGGTAGTCAGTC-30. Housekeeping genes
Table 1 Changes in rat body weight.a
Group n Body weight (grams)
Day 0 Day 9 Day 16
Normal 6 252.3  9.9 305.6  14.5 366.8  22.8
Model 84 253.8  9.0 308.6  15.4 306.7  26.5b
a Values expressed as mean (SD). b P < .05.
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CCCA TCTAT GAGG GTTACGC-30 and 50-TTTAATGTCACG-
CACGATTTC-30. Real-time RT-PCR amplification was carried
out using TRIzol reagent to extract the RNA in the synovial
tissue of rats with the above primers. Reaction volume was
25 mL and the reaction system contained samples of RNA 2
mL, Power SYBR GREEN 17.2 mL, 10 pmol primer 0.8 mL.
Reaction conditions were: 5 min at 42C, 10 s at 95C, 5 s at
95C, extending at 34 s at 60C, followed by 40 cycles.
Using ELISA to detect IL-2 and IL-17 protein expression in
serum of CIA model rats: ELISA assay was carried out ac-
cording to manufacturer’s instructions.
Statistical analysis
Measurements of AI and swelling between the model and
normal groups at the same time points were compared
using a t-test. Repeated measures ANOVA were used to
analyze changes in the same indicator for the same group of
rats at different time points. Levels of inflammatory factor
were assessed using one-way analysis of variance. Statisti-
cal analyses were performed with SPSS 18.0 statistical
software (IBM, Armonk, NY, USA).
Results
General observations
Following immunization, half of rats in the model group
showed ulceration at the injection site at the base of the
tail with an average area of 1 cm  1 cm. Normal tail
movement was not affected, and severe lesions such as
ring-shaped rupture or tail falling off were not observed.
After 9 days, rats in the model group showed decreased
appetite, slow movement, and matted fur. Ulceration and
scab formation were observed at the injection site of the
tail. After 16 days, rats in model group presented increased
skin temperature, bright red skin, swollen joints, and
limited mobility.
Changes in body weight
During Days 0 through 9, there was no significant difference
in rat body weight between the normal and model groups
(P > .05). By Day 16, body weights of model group animals
had decreased significantly compared to normal group an-
imals (P < .05) (Table 1).
Changes in swelling of limbs in the model group
Anterioreposterior and lateral diameters of forelimbs
During Days 0 through 16, anterioreposterior and lateral
diameters of the forelimbs in model group rats exhibited no
significant difference from measurements of the normal
control rats (P > .05) (Table 2).
Anterioreposterior and lateral diameters of hindlimbs
During Days 0 through 9, the anterioreposterior and
lefteright diameters of the hindlimbs in the model group
did not differ significantly from the diameters of the normalcontrol animals (P > .05). By Day 16, the anterioreposterior
and lefteright diameters of the left hindlimbs in the model
group were significantly larger than diameters of the
normal control group (P < .01). The anterioreposterior di-
ameters (P < .05) and lateral diameters (P < .01) of the
right hindlimbs were significantly different from diameters
of the normal group (Table 2).
Footpad thicknesses
During days 0 through 9, footpad thicknesses of model group
rats exhibited no significant difference when compared with
normal group animals (P > .05). By Day 16, footpads of both
left and right hindlimbs of model group rats were signifi-
cantly thicker than those of the normal group (P < .05), and
left forelimb footpads were markedly thicker than pads of
the normal group rats (P < .01) (Table 3).Arthritis index (AI) assessment
Severity of paw inflammation in the model group was
obvious. Significant differences in total AI between the
model and normal groups from Days 11 through 16 were
observed (P < .01), especially AI of the left and right hin-
dlimbs (P < .01). AI of the left and right forelimbs in the
model group from Days 0 through 16 were not significantly
different compared to the normal group (P > .05) (Tables 4).Effects of Tengmei Decoction on inflammatory
factors in CIA model rats
RT-PCR was used to detect levels of IL-2 and IL-17 mRNA
transcription. ELISA was used to detect levels of IL-2 and IL-
17 protein expression.
Effects on levels of IL-2 and IL-17 mRNA transcription
Compared to the normal control group, levels of IL-2 and IL-
17 mRNA transcription were significantly upregulated in the
model group (P < .01). Compared with the model group,
levels of IL-2 and IL-17 mRNA transcription in the positive
drug, high-dose TCM, and TCM groups were significantly
upregulated (P < .01) (Table 5).
Effects of Tengmei Decoction on levels of IL-2 and IL-17
protein expression
Compared with the normal group, levels of IL-2 and IL-17
protein expression were significantly upregulated in the
model group (P < .01) but were markedly decreased in the
positive group, high-dose TCM group, and TCM group
(P < .01) (Table 6).
Table 2 Changes in swelling of rat forelimbs and hindlimbs.a
Limb Group n Anterioreposterior diameter (mm) Lateral diameter (mm)
Day 0 Day 9 Day 16 Day 0 Day 9 Day 16
Left forelimb Normal 6 4.77  0.68 4.19  0.18 4.54  0.39 5.48  0.7 4.91  0.54 4.57  0.38
Model 84 4.65  0.43 4.22  0.32 4.82  0.64 5.09  0.5 4.55  0.42 4.97  0.48
Right forelimb Normal 6 4.48  0.68 4.5  0.28 4.74  0.25 5.38  0.72 4.78  0.47 4.91  0.53
Model 84 4.67  0.5 4.26  0.29 4.70  0.53 5.04  0.53 4.57  0.28 5.16  0.58
Left hindlimb Normal 6 7.58  0.50 7.77  0.50 7.61  0.63 6.34  0.51 6.98  0.54 5.98  0.33
Model 84 7.38  0.66 7.72  0.55 11.34  2.07c 6.63  0.63 6.46  0.60 9.02  1.61c
Right hindlimb Normal 6 7.41  0.32 7.93  0.63 7.64  1.06 6.10  0.51 7.09  0.43 6.22  0.55
Model 84 7.57  0.60 7.60  0.46 11.14  2.19b 6.57  0.66 6.44  0.42 8.87  1.80c
a Values expressed as mean (SD). b P < .05. c P < .01.
Table 3 Changes in footpad thicknesses of rat forelimbs and hindlimbs.a
Group n Left limb (mm) Right limb (mm)
Day 0 Day 9 Day 16 Day 0 Day 9 Day 16
Normal Fore 6 3.57  0.19 3.03  0.23 2.86  0.3 3.39  0.49 3.0  0.26 3.4  0.41
Model Fore 84 3.52  0.52 2.76  0.37 4.05  0.85c 3.65  0.53 2.78  0.29 3.79  0.73
Normal Hind 6 4.24  0.44 3.83  2.65 3.74  0.39 3.97  1.06 3.89  0.36 4.05  0.26
Model Hind 84 4.29  0.45 3.56  0.38 6.26  1.16b 4.28  0.43 3.64  0.31 6.24  1.39b
a Values expressed as mean (SD). b P < .05. c P < .01.
Table 4A Changes in total AI of rat limb joints.a
Group n Day 0 Day 9 Day 11 Day 12 Day 13 Day 14 Day 15 Day 16
Normal 6 0.00  0.00 0.00  0.00 0.00  0.00 0.00  0.00 0.00  0.00 0.00  0.00 0.00  0.00 0.00  0.00
Model 84 0.00  0.00 0.02  0.15 2.56  2.98b 4.21  3.50b 4.19  3.08b 4.26  2.81b 5.07  2.84b 5.99  2.97b
a Values expressed as mean (SD). b P < .01.
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Establishment of experimental animal models resembling
human diseases is an important aspect of medical research
design and a long-standing deficiency affecting research. In
recent years, animal models generated by genetic inter-
vention have become available. Although enormous prog-
ress has been achieved, animal models for many human
diseases remain lacking. With rheumatoid arthritis, a vari-
ety of autoantigens and their corresponding antibodies can
be identified in serum and synovial fluid of patients, espe-
cially the type II collagen CII antibody.6 Trentham and
colleagues used bovine CII to successfully induce arthritis in
rats, showing that collagen-induced arthritis in the rat
model has characteristics of the autoimmune response
found in human RA.7 Since then, the CIA animal model has
been improved and is still considered a classic model for
studying human RA.
The aim of our study was to validate our hypothesis that
clinical and pathologic features of the CIA rat model of
rheumatoid arthritis resemble those of the TCM syndrome
of toxic heat-stasis type painful obstruction. In our study, a
modeling success rate of 83.3% was achieved, with 70 of 84
rats exhibiting AI  4. In terms of timing for administeringthe booster injection, the protocol by Chondrex indicates 7
days,5 and other studies report 7e10 days after immuni-
zation.8,9 We observed that 7 days after immunization, a
subset of rats began to exhibit redness of the toes, elevated
skin temperature, and appearance of joint symptoms,
similar to previously reported results.10 We chose to
administer the booster dose 9 days after the priming dose,
which prevented the immune tolerance that occurs when
the intervals between priming and boosting is short. This
also avoided loss of the stimulating effect of the priming
dose if boosting had been delayed.
Research suggests that immune imbalance between os-
teoblasts and osteoclasts, as well as osteoclast prolifera-
tion and activation are important factors of bone damage
and bone metabolism disturbance, and the key to RA bone
erosion.11 Further studies suggest that monocytes, macro-
phages, and T lymphocytes can express a variety of cyto-
kines functioning in the growth, activation, and apoptosis
of osteoclasts, of which tumor necrosis factor-alpha (TNF-
a), IL-1, IL-2, IL-6, and IL-17 directly or indirectly act on
osteoclasts and mediate osteoclast differentiation.12,13
More important, activation of inflammatory mediators are
involved in the occurrence and development of synovial
lesions.14,15 In particular, IL-2 expression has been found to
be increased when the degree of RA disease activity is
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Table 5 Levels of IL-2 and IL-17 mRNA transcription in
synovial tissue of rats.
Groups n IL-2 IL-17
Normal 6 92.01  6.73 100.40  13.48
Model 6 199.78  10.81b 543.71  24.20b
Positive drug 6 110.04  12.95b 162.69  12.99b
High-dose TCM 6 145.86  10.20b 256.12  19.70b
TCM 6 147.56  6.86b 278.92  14.02b
aValues expressed as mean (SD). bP < .01.
Table 6 Levels of IL-2 and IL-17 protein expression in
serum of rats.a
Group n IL-2 IL-17
Normal 6 35.78  13.24 6.89  1.82
Model 6 53.91  10.63b 14.83  2.01c
Positive drug 6 31.99  10.11c 5.96  3.36c
High-dose TCM 6 34.99  11.97c 4.11  1.44c
TCM 6 32.00  12.02c 5.03  4.28c
aValues expressed as mean (SD). bP < .05. cP < .01.
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tokines to aggravate RA inflammation. Furthermore, in the
mice model of CIA, level of IL-2 expression varies during
different stages, such that in the early stages of RA, IL-2 is
markedly increased.17 As a powerful inflammatory factor,
IL-17 can induce expression of proinflammatory cytokines,
such as IL-6, IL-1b, TNF-a, monocyte chemotactic protein 1
(MCP-1), and granulocyte-macrophage colony-stimulating
factor GM-CSF, as well as promote proliferation, matura-
tion, and neutrophil chemotaxis. IL-17 can also increase
expression of intercellular adhesion molecule 1 (ICAM-1),
which mediates inflammatory cells and T cell infiltration in
tissue. IL-17 interacts with IL-1b, TNF-a, and interferon
gamma (IFN-g) to amplify target organ immune response
and inflammatory damage. IL-17 participates in the path-
ogenesis of autoimmune diseases and various infections by
the aforementioned effects.18,19 Therefore, immune dam-
age mediated by inflammatory cytokines is involved in the
course of RA, especially during the active stage. Clinically
active RA is characterized by systemic and local inflam-
matory responses and major presentations are accelerated
erythrocyte sedimentation rate, elevated C-reactive pro-
tein, cyclic citrullinated peptide, and rheumatoid factor,
local joint swelling, elevated skin temperature, dark red
skin, edema, and increased joint pain. Finally, large
numbers of inflammatory cells, such as T cells, B cells, and
macrophages, as well as expressed inflammatory cytokines,
accumulate in the synovial fluid, validating that the CIA
model presents typical features of active RA.
In Chinese medicine, painful blockage (bi zheng) is a
class of syndrome patterns caused by the pathogenic fac-
tors of wind, cold, dampness, or heat which invade the
channels and blood. If unresolved, the main symptoms are
joint and muscle pain. There are several patterns of painful
blockage depending on the symptomatology. Toxic heat-
blood stasis is one such pattern. Its pathogenic
172 Y. Wang et al.mechanisms are excess toxic heat, heat affecting the in-
ternal organs, constrained qi and blood, all of which lead to
slow stasis (blockage) in the joints. In this study, we used
the traditional Chinese herbal formula, Tengmei Decoction,
to test our hypothesis that the rat model of CIA mimics the
Chinese medicine pattern of painful blockage. Tengmei
decoction is widely prescribed in China to treat RA. Its
traditional functions are to clear heat, resolve toxin,
transform stasis, and remove turbidity. Our results showed
that the CIA model rats presented acute inflammation with
synovial symptoms, such as varying degrees joints swelling,
dark red skin, and increased temperature, which all
improved after the 12 weeks’ treatment with Tengmei
Decoction. Meanwhile, the levels of IL-2 and IL-17 mRNA
transcription and protein expression decreased significantly
compared with the model group after the 12 weeks’
treatment with Tengmei Decoction. This was consistent
with outcomes of our previous study showing Tengmei
decoction downregulated levels of IL-6 and TNF-a mRNA
transcription and protein expression.20 Both studies thus
appear to indicate that the CIA rat model of RA presents
pathologic and physiologic features of active RA and char-
acteristics of toxic heat-stasis painful blockage.
Limitations of our study are that in this animal model we
did not investigate articular cartilage and bone damage as
well as other pathologic changes found in late stage RA and
whether these changes can in fact be observed in this an-
imal model. These require future exploration.Conclusion
The CIA model established in this study presents both active
RA pathologic features and characteristics of the symptoms
of toxic heat-stasis painful obstruction 12 weeks after
successful establishment of an animal model. In addition,
this study may be a valuable reference for development of
animal studies with combined Eastern and Western medi-
cines in dialectics and identification of diseases.References
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